Wall Street Is Bracing for the Fed's Next Move on Rates. These 3 Stocks Win Either Way.

Key PointsEli Lilly is seeing huge demand for its GLP-1 weight-loss drugs and using the cash influx to diversify.

阅读完整 Veytics 简报

我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。